Superparamagnetic nanoparticles as blood-pool contrast agents. Contribution to MRI preclinical investigations.
Benderbous
S
S
Laboratoire Guerbet, Aulnay-sous-Bois, France.
Bonnemain
B
B
D000818:Animals; D001921:Brain / Q000098:blood supply; D002245:Carbon Dioxide / Q000097:blood; D003287:Contrast Media; D003911:Dextrans; D052203:Ferrosoferric Oxide; D006439:Hemodynamics / Q000502:physiology; D007501:Iron / Q000493:pharmacokinetics; D007668:Kidney / Q000473:pathology; D007674:Kidney Diseases / Q000175:diagnosis; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D018810:Magnetic Resonance Angiography / Q000379:methods*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D058185:Magnetite Nanoparticles; D008657:Metabolic Clearance Rate / Q000502:physiology; D010087:Oxides / Q000493:pharmacokinetics; D010100:Oxygen / Q000097:blood; D011817:Rabbits; D051381:Rats
D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; C097921:ferumoxtran-10; D002245:Carbon Dioxide; D007501:Iron; C065507:ferumoxides; D010100:Oxygen; D052203:Ferrosoferric Oxide